Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-MODE: Clopidogrel vs Aspirin Monotherapy After Short-term DAPT
NCT05320926Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Jul 2022
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in ischemic heart disease (IHD), sponsored by Yonsei University. Started Jul 2022; status: recruiting.
02
Drugs
clopidogrel
03
Conditions
ischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT05320926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320926.